awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q43086302-6A98E677-5D03-4691-BA61-0BCCB9525F13
Q43086302-6A98E677-5D03-4691-BA61-0BCCB9525F13
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43086302-6A98E677-5D03-4691-BA61-0BCCB9525F13
COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors.
P2860
Q43086302-6A98E677-5D03-4691-BA61-0BCCB9525F13
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43086302-6A98E677-5D03-4691-BA61-0BCCB9525F13
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1070dc630529637b6a007b13d63d18cb7d5c1ed7
P2860
Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthriti